“Este contenido se encuentra unicamente en inglés”

Joaquín Martínez Jefe de Grupo
T +34 917 328 000 (Ext )
jmartinezl@ext.cnio.es

The Haematological Malignancies Clinical Research Unit focuses on 3 main objectives:

• Molecular research of haematological cancers: studying of cancer induced changes at the proteomic and genomic levels. We aim to: i) find new genomic and proteomics biomarkers for a better diagnosis of these haematological diseases; ii) detect new molecular alterations as predictors of response to a treatment, for example by studying minimal residual disease; and iii) study immune mechanisms of cancer control, with a special focus on NK cells.
• In vitro & in vivo research: i) to establish the effects of new anticancer molecules in in vitro models of the disease; ii) to determine the mechanisms of resistance to anticancer drugs.
• Clinical research: translate preclinical findings to the patients through a phase I clinical trials unit.